Coya Therapeutics, Inc. (COYA)

Coya Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	50.72	46.82	38.34	32.63	5.93	4.34
Cash & Short-Term Investments	50.72	46.82	38.34	32.63	5.93	4.34
Cash Growth	42.76%	22.13%	17.51%	449.86%	36.72%	-
Accounts Receivable	-	-	-	7.5	-	-
Other Current Assets	2.54	3.12	5.97	1.07	1.25	0.24
Total Current Assets	53.26	49.94	44.31	41.2	7.18	4.58
Net Property, Plant & Equipment	0.01	0.01	0.04	0.07	0.09	0.12
Other Long-Term Assets	-	-	-	-	1.12	0.09
Total Assets	53.27	49.95	44.35	41.26	8.4	4.79
Accounts Payable	0.95	1.06	1.59	1.16	1.82	0.86
Accrued Expenses	1.36	3.61	1.39	2.97	2.01	0.29
Unearned Revenue	1.24	1.2	0.85	0.92	-	-
Total Current Liabilities	3.55	5.87	3.82	5.05	3.82	1.15
Long-Term Debt	-	-	-	-	12.97	-
Other Long-Term Liabilities	0.75	1.05	0.95	0.57	-	-
Total Long-Term Liabilities	0.75	1.05	0.95	0.57	12.97	-
Total Liabilities	4.3	6.92	4.77	5.63	16.79	1.15
Preferred Stock	-	-	-	-	8.79	8.79
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	118.14	104.99	80.31	61.49	0.68	0.47
Retained Earnings	-	-61.96	-40.74	-25.86	-17.87	-5.62
Shareholders' Equity	48.97	43.03	39.58	35.64	-8.39	3.64
Total Liabilities & Equity	53.27	49.95	44.35	41.26	8.4	4.79
Total Debt	-	0	0	0	12.97	0
Net Cash (Debt)	50.72	46.82	38.34	32.63	-7.03	4.34
Net Cash Growth	8.33%	22.13%	17.51%	-	-	-
Net Cash Per Share	2.79	2.80	2.52	3.21	-2.71	1.68
Book Value	48.97	43.03	39.58	35.64	-8.39	3.64
Book Value Per Share	2.69	2.57	2.60	3.51	-3.24	1.41
Tangible Book Value	48.97	43.03	39.58	35.64	-8.39	3.64
Tangible Book Value Per Share	2.69	2.57	2.60	3.51	-3.24	1.41

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q